Assessment of In Vitro Antidiabetic Potential of Purified Anthocyanin Extract from Floral Petals of Wild Balsam Species
Abstract
-
Diabetes is a notorious and growing clinical and public health issue. The International Diabetes Federation assumes that 592 million had diabetes by 2035 and that by 2040 the number will increase to 642 million. Cardiovascular corollary accounts for four million deaths annually attributable to diabetes. Evidence reveals that certain glucose-lowering phytochemicals can improve vascular outcomes with type 2 diabetes, which, together with better understanding of using multiple therapies concurrently, offers opportunities for beneficial personalization of medication regimens. Anthocyanins are coloured pigments and are natural antioxidants. Keeping this in focus, this study was undertaken to evaluate the in vitro antidiabetic activity in the petals of wild Impatiens balsamina L. The anthocyanin was extracted from floral petals of wild balsam species and purified to homogeneity using chromatographic techniques. Evaluation of in vitro antidiabetic properties of anthocyanin extract revealed a dose-dependent increase in the inhibitory effect on the alpha-glucosidase (200 μg/ml) and alpha-amylase enzymes (500 μg/ml) and was comparable with the standard acarbose drug (189 μg/ml and 50 μg/ml). These results indicated that anthocyanin could be used as a source of functional food and nutraceuticals. This information from wild species will be useful in finding more potent antidiabetic principle from the natural resources for the clinical development of antidiabetic therapeutics. Future studies are planned to substantiate the antidiabetic power of anthocyanin using in vivo animal models.
Keywords: Alpha amylase, alpha glucosidase, diabetes, herbal remedies, Impatiens balsamina L.
Keywords:
Alpha amylase, alpha glucosidase, diabetes, herbal remedies, Impatiens balsamina LDOI
https://doi.org/10.22270/jddt.v10i3.4050References
Riddle MC, “Diabetes Care in 2020: Following and Leading the Stories of Diabetes”, Diabetes Care, 2020; 43 (1):3-4
Fang JL, Jia SS, Lin Y, Yuan K, Jin SH, “Extraction, purification, content analysis and hypoglycemic effect of mulberry marc anthocyanin”, Phcog Mag, 2020; 16:68-75.
Akindele AJ, Otuguor E, Singh D, Ota D, Benebo AS, “Hypoglycemic, antilipidemic and antioxidant effects of valproic acid in alloxan induced diabetic rats”, Eur J Pharmacol, 2015; 762:174 83
Lupascu FG, Giusca SE, Caruntu ID, Anton A, Lupus oru CE, Profire L, “The safety profile of new antidiabetic xanthine derivatives and their chitosan based formulations”, Eur. J. Pharm. Sci, 2019; 127:71–78.
Adisakwattana S, Ngamrojanavanich N, Kalampakorn K, Tiravanitb W, Roengsumranb S, Yibchok-Anun S, “Inhibitory Activity of Cyanidin-3-rutinoside on α-Glucosidase”, Journal of Enzyme Inhibition and Medicinal Chemisty, 2004; 19(4):313-316
Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K, “Alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 2. alpha-Glucosidase inhibition by isolated acylated anthocyanins”, Journal of Agricultural and Food Chemistry, 2001; 49(4):1952-1956.
Sutharut J, Sudarat J, “Total Anthocyanin Content and Antioxidant Activity of Germinated Colored Rice”, Inter Food Res. J, 2012; 19:215-221.
Kim JS, Kwon CS, Son KH, “Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid”, Biosci Biotechnol Biochem, 2000; 64(11):2458-61
Hansawasdi C, Kawabata J, Kasai T. Alpha-amylase inhibitors from roselle (Hibiscus sabdariffa Linn.) tea. Biosci Biotechnol Biochem. 2000; 64:1041-43
Mai TT, Thu NN, Tien PG, Van Chuyen N, “Alpha-glucosidase inhibitory and antioxidant activities of Vietnamese edible plants and their relationships with polyphenol contents”, J Nutr Sci Vitaminol (Tokyo), 2007; 53:267–76.
Ramkumar KM, Thayumanavan B, Palvannan T, Rajaguru P, “Inhibitory effect of Gymnema montanum leaves on α-glucosidase activity and α-amylase activity and their relationship with polyphenolic content”, Medicinal Chemistry Research, 2010; 19(8):948-961.
Manikandan R, Vijaya A, Muthumani GD, “Phytochemical and in vitro anti-diabetic activity of methanolic extract of Psidium guajava leaves”, International Journal of Current Microbiology and Applied Sciences, 2013; 2(2):15-19
Lee EN, Song JH, Lee JS, “Screening of a potent antidementia acetylcholinesterase inhibitor-containing fruits and optimal extraction conditions”, Kor. J. Food Nutr, 2010; 23:318–323.
Banerjee A, Maji B, Mukherjee S, Chaudhuri K, Seal T, “In Vitro Antidiabetic and Anti-oxidant Activities of Methanol Extract of Tinospora sinensis”, Journal of Applied Biology & Biotechnology, 2017; 5(03):061-067
Ali MY, Paul S, Tanvir EM, Hossen MS, Rumpa NN, Saha M, Bhoumik NC, Islam MA, Hossain MS, Alam N, Gan SH, Khalil MI, “Antihyperglycemic, Antidiabetic, and Antioxidant Effects of Garcinia pedunculata in Rats. Evidence-Based Complementary and Alternative Medicine”, 2017; Article ID 2979760
Samarghandian S, Nezhad MA, Farkhondeh T, “Catechin treatment ameliorates diabetes and its complications in streptozotocin-induced diabetic rats,” Dose-Response, 2017; 15(1).
Madhuri K, Naik PR, “Modulatory effect of garcinol in streptozotocin-induced diabetic Wistar rats,” Archives of Physiology and Biochemistry, 2017; 201:1–8
Abirami A, Nagarani G, Siddhuraju P, “In vitro antioxidant, anti-diabetic, cholinesterase and tyrosinase inhibitorypotential of fresh juice from Citrus hystrix and C. maxima fruits”, Food Science and Human Wellness, 2014; 3:16–25
Ononamadu CJ, Alhassan AJ, Imam AA, Ibrahim A, Ihegboro GO, Owolarafe AT, Sule MS, “In vitro and in vivo evaluation of the antidiabetic and antioxidant activity of methanol extract/ solvent fractions of Ocimum canum leaves”, Caspian J Intern Med, 2019; 10(2):162-175
Sarikaphuti A, Nararatwanchai T, Hashiguchi T, Ito T, Thaworanunta S, Kikuchi K, Oyama Y, Maruyama I, Tancharoen S, “Preventive effects of Morus alba L. anthocyanins on diabetes in Zucker diabetic fatty rats”, Experimental And Therapeutic Medicine,2013; 6:689-695
Rhabaso Lhoret R, Chiasson JL, Glucosidase inhibitors. In: Defronzo RA, Ferrannini E, Keen H, Zimmet P. (Eds.), International Textbook of Diabetes Mellitus, Vol. 1, third ed. John Wiley and Sons Ltd., UK; 2004. P. 901-914
Strugała P, Dzydzan O , Brodyak I , Kucharska AZ , Kuropka P, Liuta M , Kaleta-Kuratewicz K, Przewodowska A , Michałowska D, Gabrielska J, Sybirna N, “Antidiabetic and Antioxidative Potential of the Blue Congo Variety of Purple Potato Extract in Streptozotocin-Induced Diabetic Rats”, Molecules 2019; 24(17):3126
Sundarrajan T, Velmurugan V, Manikandan K, Jothieswari D, “A study of In-vitro hypoglycemic and glucose uptake activity of isolated compound from ethanolic leaf extract of Amaranthus tristis Linn.”, Phcog Res, 2019; 11:37-40
Odeyemi S, Dewar J, “In Vitro Antidiabetic Activity A_ecting Glucose Uptake in HepG2 Cells Following Their Exposure to Extracts of Lauridia tetragona (L.f.) R.H.”, Archer Processes, 2020; 8:33;
Shetti AA, Sanakal RD, Kaliwal BB, “Antidiabetic effect of ethanolic leaf extract of Phyllanthus amarus in alloxan induced diabetic mice”, Asian Journal of Plant Science and Research, 2012; 2(1):11-15
Rynjah CV, Boruah P, Majaw S, “Evaluation of hypoglycemic and antihyperglycemic effect of aqueous-methanolic leaves extract of two medicinal plants of Meghalaya in mice”, International Journal of Pharmacological Research, 2016; 6(7):256-263
Helal EGE, Sharaf HA, Mattar FE, “Anti – diabetic and anti-obesity effects of plant extract from Cleome droserifolia (SAMWA)”, The Egyptian Journal of Hospital Medicine, 2002; 9:85 – 101
Ahmed SM, Vrushabendra Swamy BM, Dhanapal PGR, Chandrashekara VM, “Anti-Diabetic Activity of Terminalia catappa Linn. Leaf Extracts in Alloxan-Induced Diabetic Rats”, Iranian Journal Of Pharmacology & Therapeutics, 2005; 4(1):36-39
Nagar R, Patel R, “Anti-diabetic Activity of Few India Indigenous Medicinal Plants”, Int. J. Pharm. Sci. Drug Res, 2019; 11(6):278-283.
Muchandi A, Jadhav AS, Patil SB, Patil SA, Jadhav NB, “Antioxidant and In Vitro Antidiabetic Activities of Methanol Extract of Piper cubeba L.,” International Research Journal of Pharmacy and Medical Sciences (IRJPMS), 2018; 1(3):1-4
Published
Abstract Display: 889 
PDF Downloads: 834 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.